Blume Capital Management, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Blume Capital Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $28,701 - $34,048	-50 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $22,336 - $27,410	50 New	50 $24,000
Q4 2019 Feb 05, 2020	SELL	$274.13 - $376.51 $13,706 - $18,825	-50 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$372.08 - $439.57 $17,115 - $20,220	-46 Reduced 47.92%	50 $21,000
Q4 2018 Feb 05, 2019	BUY	$335.82 - $403.04 $32,238 - $38,691	96 New	96 $36,000
Q2 2018 Aug 02, 2018	SELL	$284.6 - $344.99 $27,037 - $32,774	-95 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$431.38 - $504.0 $40,981 - $47,880	95	95 $42,000

1,534

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Blume Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Blume Capital Management, Inc. with notifications on news.